Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:WMS
NYSE:WMSBuilding

Is Advanced Drainage Systems (WMS) Pricing In Too Much Optimism After Its Recent Rally

If you are wondering whether Advanced Drainage Systems is still fairly priced after its recent run, this article will walk through what the current share price might be implying about value. The stock last closed at US$153.09, with returns of 2.5% over the past 30 days and 23.1% over the past year. Over the last 7 days, the return was a 3.9% decline, and the 3 year and 5 year returns were 62.4% and 89.8% respectively. Recent coverage has focused on Advanced Drainage Systems as a key player...
LSE:LLOY
LSE:LLOYBanks

A Look At Lloyds Banking Group (LSE:LLOY) Valuation After Strong 1 Year Shareholder Returns

Lloyds Banking Group (LSE:LLOY) has drawn fresh attention after recent share price moves and improving return figures, prompting investors to reassess how its current valuation lines up with its latest financial profile. See our latest analysis for Lloyds Banking Group. That recent 18.39% 90 day share price return, alongside a 4.79% 30 day gain and £1.0165 latest share price, contrasts with a more modest 2.43% year to date share price return. The 1 year total shareholder return of 72.68%...
NYSE:ALK
NYSE:ALKAirlines

Alaska Air Group (ALK) Thin 0.7% Net Margin Tests Bullish Earnings Growth Narratives

Alaska Air Group (ALK) has wrapped up FY 2025 with Q4 revenue of US$3.6 billion and basic EPS of US$0.18, alongside net income of US$21 million. This sets a measured tone for its latest update. The company has seen revenue move from US$3.5 billion and EPS of US$0.56 in Q4 2024 to US$3.6 billion and EPS of US$0.18 in Q4 2025. Trailing twelve month revenue sits at US$14.2 billion with EPS of US$0.85 and a net margin that remains thin after a large one off loss in the last year, keeping the...
NYSE:APH
NYSE:APHElectronic

Has Amphenol (APH) Run Too Far After A 97% One Year Share Price Surge

Wondering if Amphenol's share price still makes sense after such a strong run, or if you might be looking at a stock that is already priced for perfection? The stock closed at US$150.99, with a 1 year return of 97.1% and a 5 year return of 406.5%. Over the last 7 days it saw a 2.2% decline, while the last 30 days showed a 9.5% gain, which can change how the market views both its growth potential and risk. Recent market attention on Amphenol has focused on its position as a major interconnect...
NYSE:DG
NYSE:DGConsumer Retailing

Assessing Dollar General (DG) Valuation After Recent Share Price Momentum And Mixed Return History

Why Dollar General stock is drawing fresh attention Dollar General (DG) shares have been active recently, with the stock near US$146.92 and showing mixed short term returns, including a modest gain over the past month and a stronger move in the past 3 months. See our latest analysis for Dollar General. Against a longer backdrop where the 1 year total shareholder return is about 109% but the 3 and 5 year total shareholder returns remain negative, the recent 44.1% 3 month share price return...
NYSE:BHC
NYSE:BHCPharmaceuticals

A Look At Bausch Health (BHC) Valuation After RED-C Phase 3 Trial Setback

Bausch Health Companies (BHC) is back on investor radar after the company reported that its global Phase 3 RED-C program in hepatic encephalopathy prevention did not meet its primary endpoint. This has prompted closer scrutiny of its pipeline. See our latest analysis for Bausch Health Companies. The RED-C setback landed alongside a softer share price backdrop, with a 1 day share price return of 10.05% and a 7 day share price return of 15.33%, while the 1 year total shareholder return of...
NasdaqGS:METC
NasdaqGS:METCMetals and Mining

A Look At Ramaco Resources (METC) Valuation After Jefferies Upgrade And Brook Mine Critical Minerals Focus

Recent analyst upgrades at Jefferies have put fresh attention on Ramaco Resources (METC), as investors weigh metallurgical coal pricing, expected operational execution, and the longer term potential of the Brook Mine critical minerals project. See our latest analysis for Ramaco Resources. The Jefferies upgrade has arrived during a powerful rebound in the shares, with a 7 day share price return of 32.70% and a 30 day share price return of 52.48% lifting the stock after a 20.50% decline over 90...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Ally Financial (ALLY) Valuation Check After Recent Share Price Weakness

Ally Financial (ALLY) has been moving lower recently, with the share price down about 2% over the past day and 11% over the past month, leaving the stock in negative territory year to date. See our latest analysis for Ally Financial. The recent 11.2% 30 day share price decline and year to date share price return of negative 10.2% contrast with Ally Financial's 1 year total shareholder return of 8.9%. This hints at fading short term momentum against a still positive multi year outcome. If this...
NYSE:AON
NYSE:AONInsurance

How Investors May Respond To Aon (AON) Spotlighting Parametric Solutions Amid Surging Climate-Driven Insurance Losses

Aon has released its 2026 Climate and Catastrophe Insight report, showing that severe convective storms have overtaken tropical cyclones as the costliest insured peril of the 21st century, with insured losses in 2025 again exceeding US$100 billion. The report underlines how rising weather-related losses are increasing demand for alternative risk transfer solutions such as parametric insurance and catastrophe bonds, positioning insurance intermediaries at the center of resilience planning for...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy Dividend Hike Highlights Confidence In Cash Returns And Growth

NRG Energy (NYSE:NRG) announced an 8% increase in its quarterly dividend. The higher payout was approved by the Board and aligns with the company’s stated annual dividend growth targets. The move signals continued focus on shareholder returns and disciplined capital allocation. For investors watching NRG Energy at a share price of $149.3, this dividend hike highlights that the company is emphasizing cash returns as part of its equity story. Over the past year, the stock is up 34.7%, and...
NYSE:CTVA
NYSE:CTVAChemicals

Corteva’s Telbek PRO Fungicide Puts Wheat Disease Control In Focus

Corteva (NYSE:CTVA) has introduced Telbek PRO fungicide for wheat growers in Canada. The product features a novel mode of action targeting Fusarium head blight and other key wheat diseases. The launch is aimed at supporting yield stability and expanding Corteva's crop protection portfolio. Corteva, a major player in seed and crop protection, is adding Telbek PRO to its Canadian lineup at a time when disease management is a central concern for wheat producers. Fusarium head blight remains a...
DB:3CA
DB:3CAElectrical

Plejd (DB:3CA) Margin Expansion Reinforces Bullish Earnings Narratives Despite Rich P/E

Plejd (DB:3CA) has wrapped up FY 2025 with fourth quarter revenue of 329.1 million SEK and Basic EPS of 5.63 SEK, rounding out a year where trailing twelve month revenue reached 1,083.0 million SEK and EPS came in at 16.12 SEK, underpinned by net income of 180.2 million SEK. Over the last few quarters, the company has seen quarterly revenue range from 245.3 million SEK to 329.1 million SEK, while quarterly Basic EPS moved between 3.15 SEK and 5.63 SEK as net income shifted from 35.2 million...
TSX:IVN
TSX:IVNMetals and Mining

Why Ivanhoe Mines (TSX:IVN) Is Up 8.0% After Record Kamoa-Kakula Copper Output

Ivanhoe Mines reported that its Kamoa-Kakula operation delivered record 2025 production, including 388,838 tonnes of copper in concentrate and strong fourth-quarter performance above the Phase 3 concentrator’s design capacity, while zinc output also reached new highs and met guidance. At the same time, the Platreef Mine in South Africa has moved from first concentrate production in late 2025 to a rapid development phase, with the upcoming Shaft #3 expected to lift hoisting capacity to 5.0...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Is Pagaya’s AI Partnership With Achieve And Product Diversification Altering The Investment Case For Pagaya Technologies (PGY)?

Pagaya Technologies recently expanded its reach in marketplace lending through a new partnership with digital personal finance company Achieve, integrating its AI-powered underwriting technology to widen consumer access to personal loans. The company’s upcoming presentation at the 28th Annual Needham Growth Conference in New York highlights how it is showcasing its diversification beyond personal loans into auto point-of-sale and other product areas to investors. Next, we’ll examine how...
ASX:CBA
ASX:CBABanks

What Commonwealth Bank of Australia (ASX:CBA)'s Rate Moves and Apple Pay Push Mean For Shareholders

In recent weeks, Commonwealth Bank of Australia has lifted term deposit and fixed home loan rates ahead of an anticipated Reserve Bank cash rate move, while also pressing Parliament for fairer access to Apple’s iPhone NFC payment infrastructure. This combination of pricing changes and policy advocacy highlights how CBA is positioning itself at the intersection of monetary policy shifts and competition in digital payments. With these rate moves and regulatory push on Apple Pay in focus,...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Sandisk’s Post Spinoff Surge Puts AI Memory Leadership In Focus

Sandisk (NasdaqGS:SNDK) has seen a surge in performance following its spin off from Western Digital. The company has emerged as a market leader in NAND flash memory during an AI driven global memory shortage. Sandisk is expanding partnerships with major hyperscale cloud providers that rely on high capacity storage for AI workloads. Sandisk operates at the heart of the NAND flash memory market, supplying storage that underpins data centers, consumer devices, and AI infrastructure. As AI...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Does Plug Power (PLUG) Price Reflect Its DCF Value After Recent Share Price Rebound?

If you are trying to figure out whether Plug Power's share price lines up with its underlying value, this breakdown will help you see what the current market is really pricing in. The stock last closed at US$2.50, with returns of 5.9% over 7 days, 19.0% over 30 days, 12.1% year to date, 20.2% over 1 year, and longer-term 3-year and 5-year returns of 84.2% and 96.0% declines. These moves have come alongside ongoing investor attention on hydrogen fuel cell and clean energy names, as well as...
NYSE:UNF
NYSE:UNFCommercial Services

How UniFirst’s (UNF) Multi-Site LED Upgrade Could Reshape Its Cost and Sustainability Profile

Redaptive previously announced the completion of the first phase of a multi-site energy modernization program with UniFirst, upgrading LED lighting across 39 U.S. facilities covering more than 2.5 million square feet and aiming to cut energy use and emissions over the coming decade. This program is projected to save UniFirst several million dollars in energy costs while avoiding over 21,000 metric tons of CO2 emissions, underscoring how operational efficiency and sustainability initiatives...
SEHK:2190
SEHK:2190Medical Equipment

A Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After Investor Open Day Showcases Endovascular Portfolio

Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors and sell side analysts. See our latest analysis for Zylox-Tonbridge Medical Technology. The Investor Open Day comes after a strong run in the shares, with a 30 day share price return of 16.37% and a 1 year total shareholder return of 135.76%. This suggests momentum has been building rather than...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Did CEO Share Sale and Casgevy Rollout Just Shift CRISPR Therapeutics' (CRSP) Investment Narrative?

In recent days, CRISPR Therapeutics has drawn attention as a pre-arranged share sale by CEO Samarth Kulkarni coincided with fresh commentary on its development pipeline and upcoming earnings expectations. At the same time, investor focus has intensified on the early commercial rollout of Casgevy, the company’s lead gene-edited therapy, as a potential long-term growth driver despite near-term earnings pressure. We’ll now examine how the CEO’s planned share sale and Casgevy’s commercial...